Macaluso LLP represented the U.S. office of a global sovereign wealth fund as lead investor in a $180 million structured investment backed by crop loans.
ABS, AGRICULTURE, ASIA, FINANCIAL SERVICES, FUNDS, GOVERNMENT, INTERNATIONAL, SECURITIES OFFERINGS, STRUCTURED FINANCE, COMMERCIALIZATION, CAPITAL MARKETS
The firm assisted a U.S.-based family office in the sale of its nanotech portfolio business located in international affiliates in Japan, Singapore and Israel to a NASDAQ-listed company.
M&A, TECHNOLOGY, INTERNATIONAL, COMMERCIALIZATION, SECURITIES OFFERINGS, ASIA, MIDDLE-EAST, REGULATORY, RESTRUCTURING, CAPITAL MARKETS
Our managing partner acted as treasury counsel with responsibility for all global treasury activities of a $120 billion subsidiary of a Fortune 25 company for over a dozen years with respect to virtually all its capital markets and structured finance activities around the world. He was part of the on-the-ground team that acquired the business that became the company’s London and, ultimately, European operations. He was a member of the leadership team that built and put into place the first funding facilities for the new European treasury group and set up its operations.
COUNSEL SERVICES, FINANCIAL SERVICES, TREASURY, U.S., EUROPE, SOUTH AMERICA, SECURITIES OFFERINGS, RESTRUCTURING, ABS, STRUCTURED FINANCE, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
We assisted a blockchain-enabled secured mortgage aggregation platform operating as a decentralized autonomous organization (DAO) in connection with the legal structure of its base platform and operations.
TECHNOLOGY, STRUCTURED FINANCE, COMMERCIALIZATION, FINANCIAL SERVICES, ABS, SECURITIES OFFERINGS, CAPITAL MARKETS
The firm represents a gaming company in connection with the building of its own platform for a blockchain and non-fungible token (NFT)-based “metaverse” virtual reality (VR) game for the Oculus platform.
TECHNOLOGY, COMMERCIALIZATION, SPORTS AND ENTERTAINMENT
Macaluso LLP successfully represented a syndicate of lenders in the workout of a loan facility collateralized by significant 16th century art.
FINANCIAL SERVICES, RESTRUCTURING, STRUCTURED FINANCE, ABS, BANKS, CAPITAL MARKETS
Our attorneys served as counsel to issuers, sponsors, and commercial and investment banks, handling the issuance of asset-backed securities and other structured finance transactions across several dozen asset classes through direct structures, private placements, 144A offerings, asset-backed commercial paper programs, structured investment vehicles and asset-backed shelves.
FINANCIAL SERVICES, BANKS, STRUCTURED FINANCE, ABS, REGULATORY, RESTRUCTURING, SECURITIES OFFERINGS, CAPITAL MARKETS
Counsel to a health care company in the growth stage currently rolling out its cardiovascular program in international markets. Assisted company in setting up U.S. and Hong Kong operations. Responsible for managing the local medical privacy, local FDA and regulatory approach, working with partners and investors across U.S. and Asia. Also represented the company in its Middle East expansion, beginning in the U.A.E.
HEALTH CARE, INTERNATIONAL, ASIA, MIDDLE-EAST, REGULATORY, COMMERCIALIZATION, CAPITAL MARKETS
As counsel to domestic and global agribusiness conglomerates and middle-market companies, European and U.S. money center banks and sector-focused funds, handling several billion dollars’ worth of transactions, projects and financings across the agriculture sector.
BANKS, FUNDS, PROJECT FINANCE, U.S., EUROPE, ASIA, AGRICULTURE, INTERNATIONAL, REGULATORY, RESTRUCTURING, SECURITIES OFFERINGS, CAPITAL MARKETS
Assisted a leading medical research institution and related entities in connection with their efforts to commercialize intellectual properties.
HEALTHCARE, COMMERCIALIZATION, M&A, INTERNATIONAL, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, U.S., SOCIAL IMPACT, CAPITAL MARKETS
As a senior administrative officer at the Minnesota Department of Commerce, a Macaluso LLP lawyer directed health care reform efforts for the Department of Health on methods to reduce annual state health care costs of $40 billion through administrative uniformity and simplification, attaining primary consensus among health care industry leaders (representing health care providers and payers) on standardized, electronic medical billing to reduce costs and end over 14 years of piecemeal agreement, resulting in an annual estimated reduction in costs of $56 million.
GOVERNMENT, REGULATORY, HEALTHCARE, TECHNOLOGY, U.S., CAPITAL MARKETS
The firm acted as adviser to principally U.S. private equity funds and investors making investments in Asia, including in or through China, Japan, Malaysia, Indonesia, Vietnam, Singapore and Hong Kong.
FUNDS, INTERNATIONAL, ASIA, M&A, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, HEALTHCARE, AGRICULTURE, CAPITAL MARKETS
Acted as chief strategist in the restructuring of several portfolio companies of a fund in the health care, life science, intellectual property (IP) and tech sectors, commercializing medical-related advances of prominent medical research institutions.
COUNSEL SERVICES, HEALTHCARE, TECHNOLOGY, FUNDS, COMMERCIALIZATION, M&A, SECURITIES OFFERINGS, RESTRUCTURING, CAPITAL MARKETS
M&A transactions on behalf of acquirers and targets, including partial spin-offs and full divestitures, in connection with restructurings and otherwise of finance companies, banks and asset-managers as well as companies in the health care and agriculture sectors.
M&A, HEALTHCARE, FINANCIAL SERVICES, AGRICULTURE, INTERNATIONAL, RESTRUCTURING, CAPITAL MARKETS
We served as general counsel for a company in the direct investment and asset management business with operations in U.S., Asia and Europe. Responsible for global legal strategy and execution for all domestic and international investments, transactions and operations of the company, including regulatory matters. The client owns and manages a portfolio of directly held private investments in established and growth stage companies, which include leading domestic and international brands, companies and technologies primarily in sectors such as health care, agriculture technology, fintech, and sports and entertainment. Developed the company’s risk management and portfolio intake and monitoring procedures.
COUNSEL SERVICES, HEALTHCARE, SPORTS & ENTERTAINMENT, FINANCIAL SERVICES, INTERNATIONAL, U.S., ASIA, EUROPE, MIDDLE-EAST, AGRICULTURE, TECHNOLOGY, REGULATORY, CAPITAL MARKETS
On behalf of several prominent private investment funds, our attorneys handled the design and formation of credit opportunity and private equity funds and the structuring and execution of various transactions to acquire, finance and leverage fund assets on the one hand and monetize or dispose of fund assets on the other hand.
FUNDS, M&A, INTERNATIONAL, SECURITIES OFFERINGS, REGULATORY, U.S., FINANCIAL SERVICES, CAPITAL MARKETS
Developed an innovative ag financing program with one of the largest agribusiness companies in the world, with facilities ranging from $100 million to $600 million and in connection with its $1.2 billion divestiture of one of its finance subsidiaries.
FINANCIAL SERVICES, AGRICULTURE, ABS, STRUCTURED FINANCE, M&A, CAPITAL MARKETS
Multibillion-dollar/euro government bailouts in the U.S. and Europe. Restructurings and workouts of financial institutions, funds, programs and complex instruments. Clients called on teams led by the firm’s managing partner from the inception of the capital markets crisis. He assisted global banking institutions in the U.S. and Europe, issuers, sponsors of complex instruments and investment funds in maintaining, obtaining and, in some cases, restructuring or otherwise working out privately and through government programs over $150 billion of liquidity.
FINANCIAL SERVICES, U.S., EUROPE, BANKS, STRUCTURED FINANCE, INTERNATIONAL, ABS, REGULATORY, RESTRUCTURING, CAPITAL MARKETS
As an attorney-adviser (international) in the office of General Counsel at the U.S. Department of Commerce in Washington, D.C., one of our lawyers advised client agencies within the International Trade Administration (ITA) on export promotion and U.S. government advocacy supporting the interests of U.S. companies. The attorney provided legal advice to assist U.S. companies with issues involving foreign trade compliance under applicable trade agreements (particularly WTO and NAFTA, prior to the USMCA) and U.S. trade statutes including Sections 301 (U.S. trade retaliation) and 201 (safeguards) of the Trade Act of 1974 and Section 301 and Section 337 (intellectual property rights).
GOVERNMENT, INTERNATIONAL, TRADE, REGULATORY, CAPITAL MARKETS
Managed pre-listing and presale process for high-growth companies in Asia through private equity rounds including in some cases a complete restructuring of the company.
FUNDS, ASIA, REGULATORY, SECURITIES OFFERINGS, RESTRUCTURING, CAPITAL MARKETS
The firm served as adviser on structuring and negotiating a 300 million euro portfolio of Italian mortgage assets using Malta SPV structure.
FINANCIAL SERVICES, STRUCTURED FINANCE, EUROPE, ABS, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
The firm performed pre-IPO and/or pre-PE investment due diligence and managed pre-investment and, later, the pre-exit strategy relative to companies in various sectors in China, including pharmaceutical companies, retailers, advanced robotics, printing, plastics, and food and beverage companies.
FUNDS, M&A, HEALTHCARE, TECHNOLOGY, AGRICULTURE, INTERNATIONAL, REGULATORY, CAPITAL MARKETS
Advised social impact private equity fund in structuring its investments and strategy for investments into China, Indonesia, and Vietnam and assessed its infrastructure for making investments generally.
FUNDS, SOCIAL IMPACT, ASIA, REGULATORY, CAPITAL MARKETS
Lead counsel for the arranger for a $10 billion multistrategy, multi-asset “club” conduit funding facility on behalf of the issuer and as lead counsel for the transaction divided into subfacilities, including a master trust and options for committed long-term conduit financing.
FINANCIAL SERVICES, STRUCTURED FINANCE, ABS, BANKS, REGULATORY
Lead counsel on behalf of the lead bank/arranger with regard to a single $9 billion structured loan involving four public companies, including two of the world’s largest banks.
FINANCIAL SERVICES, BANKS, STRUCTURED FINANCE, ABS, REGULATORY, CAPITAL MARKETS
As counsel to the originator, the first-of-its-kind innovative $26 billion partial liquidity enhanced extendible notes and commercial paper program.
FINANCIAL SERVICES, STRUCTURED FINANCE, SECURITIES OFFERINGS, ABS, BANKS, REGULATORY, CAPITAL MARKET